EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Increased uptake of tuberculosis preventive therapy (TPT) among people living with HIV following the 100-days accelerated campaign: A retrospective review of routinely collected data at six urban public health facilities in Uganda

Joseph Musaazi iD, Christine Sekaggya-Wiltshire, Stephen Okoboi, Stella Zawedde-Muyanja iD, Mbazi Senkoro, Nelson Kalema, Paul Kavuma iD, Proscovia M Namuwenge, Yukari C Manabe iD, Barbara Castelnuovo, Agnes Kiragga

PLOS ONE · 2023

DOI: 10.1371/journal.pone.0268935 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Joseph Musaazi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Diseases Institute, Makerere University College of Health Sciences, Kampala, Uganda. Hauptthemen laut MEDLINE: HIV Infections, Tuberculosis. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: FIC NIH HHS, PEPFAR, European & Developing Countries Clinical Trials Partnership (EDCTP) - East Africa TB NODE.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tuberculosis preventive therapy (TPT) effectively decreases rates of developing active tuberculosis disease in people living with HIV (PLHIV) who are at increased risk. The Uganda Ministry of Health launched a 100-day campaign to scale-up TPT in PLHIV in July 2019. We sought to examine the effect of the campaign on trends of TPT uptake and characteristics associated with TPT uptake and completion among persons in HIV care. We retrospectively reviewed routinely collected data from 2016 to 2019 at six urban public health facilities in Uganda. HIV care database and paper-based TPT registers at six public health facilities in Kampala, Uganda were retrospectively reviewed. Estimated trends of TPT (given as Isoniazid monotherapy) uptake and completion across the 4 years, among PLHIV aged 15 years and above, and factors associated, were examined using Poisson regression model with robust standard errors using generalized estimating equation (GEE) models. On average, a total of 39,774 PLHIV aged 15 years and above were eligible for TPT each calendar year at the six health facilities. Across all 4 years, more than 70% were females (range: 73.5% -74.6%) and the median age ranged from 33 to 34 years. From 2016 quarter one to 2019 quarter two, TPT uptake was consistently below 25%, but, as expected, the uptake significantly increased by about 3-folds from 22.1% to 61.2%, in 2019 quarter two (i.e. before the roll-out of the 100-day accelerated TPT intervention) and quarter three (i.e. after the roll-out of the 100-day accelerated TPT intervention) respectively. This increase remained highly significant even after adjusting for patients’ baseline characteristics (adjusted prevalence ratio [aPR] = 2.58 [95%CI 2.45, 2.72], P-value

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsTuberculosisFemaleHumansPregnancyAdultMaleRetrospective StudiesUgandaRoutinely Collected Health DataHealth FacilitiesAntitubercular Agents

Substanzen

Antitubercular Agents

Autor:innen und Institutionen

  • Infectious Diseases Institute, Makerere University College of Health Sciences, Kampala, Uganda.
  • National Institute for Medical Research, Muhimbili Centre, Dar-es-Salaam, Tanzania.
  • National Tuberculosis and Leprosy Program, Uganda Ministry of Health, Kampala, Uganda.
  • Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.

ORCID-Profile: Joseph Musaazi, Stella Zawedde-Muyanja, Paul Kavuma, Yukari C Manabe

Förderung

  • FIC NIH HHS
  • PEPFAR
  • European & Developing Countries Clinical Trials Partnership (EDCTP) - East Africa TB NODE
  • Fogarty International Center, National Institutes of Health

Zitieren

APA

Musaazi, J., Sekaggya-Wiltshire, C., Okoboi, S., Zawedde-Muyanja, S., Senkoro, M., Kalema, N., Kavuma, P., Namuwenge, P. M., Manabe, Y. C., Castelnuovo, B., & Kiragga, A. (2023). Increased uptake of tuberculosis preventive therapy (TPT) among people living with HIV following the 100-days accelerated campaign: A retrospective review of routinely collected data at six urban public health facilities in Uganda. PLOS ONE. https://doi.org/10.1371/journal.pone.0268935

Vancouver

Musaazi J, Sekaggya-Wiltshire C, Okoboi S, Zawedde-Muyanja S, Senkoro M, Kalema N, et al. Increased uptake of tuberculosis preventive therapy (TPT) among people living with HIV following the 100-days accelerated campaign: A retrospective review of routinely collected data at six urban public health facilities in Uganda. PLOS ONE. 2023. doi:10.1371/journal.pone.0268935

BibTeX
@article{Musaazi2023,
  author = {Musaazi, Joseph and Sekaggya-Wiltshire, Christine and Okoboi, Stephen and Zawedde-Muyanja, Stella and Senkoro, Mbazi and Kalema, Nelson and Kavuma, Paul and Namuwenge, Proscovia M and Manabe, Yukari C and Castelnuovo, Barbara and Kiragga, Agnes},
  title = {Increased uptake of tuberculosis preventive therapy (TPT) among people living with HIV following the 100-days accelerated campaign: A retrospective review of routinely collected data at six urban public health facilities in Uganda},
  journal = {PLOS ONE},
  year = {2023},
  doi = {10.1371/journal.pone.0268935}
}
Kostenlos starten →